1 March 2011
Paloma Pharmaceuticals Update on Ocular Clinical and Oncology Programs
21 February 2011
Paloma Pharmaceuticals presents at the CHI Early Oncology Partnering meeting


2 November 2010
Paloma Pharmaceuticals presents at the CHI Targeting the PI3K Pathway Inhibiting Signaling of PI3K, Akt and mTOR


13 September 2010
Paloma Pharmaceuticals Presents Activity of P529 in an Infantile Spasm Animal Model
25 August 2010
Paloma Pharmaceuticals presents at the American Chemical Society Annual meeting


27 May 2010
Paloma Pharmaceuticals presents at the GTC Bio Ocular Diseases and Drug Discovery meeting


19 April 2010
Paloma Pharmaceuticals Presents at the 101st Meeting of the American Association of Cancer Research
4 February 2010
Paloma Pharmaceuticals Receives Approval to Enter Phase I Clinical Trials
16 November 2009
Paloma Pharmaceuticals Presents at the AACR-NCI-EORTC
6 May 2009
Association for Research in Vision and Ophthalmology
24 February 2009
Paloma Pharmaceuticals published paper in British Journal of Cancer
17 November 2008
AACR special conference in cancer research
15 April 2008
American Association for Cancer Research
13 February 2008
VentureWire Lifescience
8 February 2008
The Association for Research in Vision and Ophthalmology
7 February 2008
10th International Symposium on Anti-angiogenic Agents
12 November 2007
IBC 5th Annual International Conference on Anti-angiogenesis
16 April 2007
IBC 4th International Conference on Ocular Anti-angiogenesis